PL362803A1 - Nowy sposób i kompozycje do miejscowego leczenia choroby Meniere'a, szumu w uszach i/lub utraty słuchu - Google Patents

Nowy sposób i kompozycje do miejscowego leczenia choroby Meniere'a, szumu w uszach i/lub utraty słuchu

Info

Publication number
PL362803A1
PL362803A1 PL02362803A PL36280302A PL362803A1 PL 362803 A1 PL362803 A1 PL 362803A1 PL 02362803 A PL02362803 A PL 02362803A PL 36280302 A PL36280302 A PL 36280302A PL 362803 A1 PL362803 A1 PL 362803A1
Authority
PL
Poland
Prior art keywords
meniere
tinnitus
disease
compositions
novel method
Prior art date
Application number
PL02362803A
Other languages
English (en)
Inventor
Helge Rask-Andersen
Johan Stjernschantz
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Publication of PL362803A1 publication Critical patent/PL362803A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fertilizers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL02362803A 2001-01-19 2002-01-15 Nowy sposób i kompozycje do miejscowego leczenia choroby Meniere'a, szumu w uszach i/lub utraty słuchu PL362803A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100158A SE0100158D0 (sv) 2001-01-19 2001-01-19 Novel method and composition for local treatment of Meniere´s disease and tinnitus
PCT/SE2002/000062 WO2002056890A1 (en) 2001-01-19 2002-01-15 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss

Publications (1)

Publication Number Publication Date
PL362803A1 true PL362803A1 (pl) 2004-11-02

Family

ID=20282672

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02362803A PL362803A1 (pl) 2001-01-19 2002-01-15 Nowy sposób i kompozycje do miejscowego leczenia choroby Meniere'a, szumu w uszach i/lub utraty słuchu

Country Status (14)

Country Link
US (1) US7498360B2 (pl)
EP (1) EP1351693B1 (pl)
JP (2) JP4202135B2 (pl)
CN (1) CN1307998C (pl)
AT (1) ATE470446T1 (pl)
AU (1) AU2002219765B2 (pl)
BR (1) BR0206568A (pl)
CA (1) CA2434272C (pl)
DE (1) DE60236639D1 (pl)
MX (1) MXPA03006439A (pl)
NZ (1) NZ526972A (pl)
PL (1) PL362803A1 (pl)
SE (1) SE0100158D0 (pl)
WO (1) WO2002056890A1 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050171054A1 (en) * 2001-01-19 2005-08-04 Helge Rask-Andersen Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
US20040133099A1 (en) 2002-12-18 2004-07-08 Dyer R. Kent Otologic nanotechnology
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
JPWO2006003910A1 (ja) * 2004-06-30 2008-04-17 小野薬品工業株式会社 メニエール病の予防および／または治療剤
EP1986666A1 (en) * 2006-02-06 2008-11-05 Synphora AB Novel method and compositions for treatment of tinnitus
BRPI0910850B1 (pt) 2008-04-21 2022-06-14 Otonomy, Inc. Composição intratimpânica compreendendo fator neurotrófico de crescimento derivado do cérebro (bdnf) para o tratamento ou prevenção da perda auditiva
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
CN102026623B (zh) 2008-05-14 2013-08-14 奥德纳米有限公司 用于治疗耳部病症的控制释放皮质类固醇组合物和方法
US8648119B2 (en) 2008-05-23 2014-02-11 Otonomy, Inc. Controlled release immunomodulator compositions and methods for the treatment of otic disorders
US8846770B2 (en) * 2008-06-18 2014-09-30 Otonomy, Inc. Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
WO2010011466A2 (en) 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8349353B2 (en) 2008-06-27 2013-01-08 Otonomy, Inc. Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
AU2014200457B2 (en) * 2008-07-21 2016-07-28 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US8399018B2 (en) 2008-07-21 2013-03-19 Otonomy, Inc. Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
US8496957B2 (en) 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
CN102105133B (zh) 2008-07-21 2015-06-17 奥德纳米有限公司 控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
US9173864B2 (en) * 2008-10-22 2015-11-03 House Ear Institute Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
JP2016534121A (ja) 2013-08-27 2016-11-04 オトノミ—，インク． 小児の耳の病気の処置
EP3478269A4 (en) 2016-06-29 2020-04-08 Otonomy, Inc. OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5176654B1 (en) 1990-12-07 1999-12-07 Simeon B Schreiber Method and apparatus for otologic administration of medicament
WO1999030718A2 (en) * 1997-12-18 1999-06-24 Nathan Earl Scott PROSTAGLANDIN E2/F2α COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL
KR950000664A (ko) * 1993-06-14 1995-01-03 우에노 도시오 신규한 13,14-디히드로-피지에프 2 베타(PGF2β) 및 이의 이소프로필 에스테르
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
KR950032113A (ko) * 1994-03-22 1995-12-20 우에노 도시오 프로스타글란딘 에프 에스테르
US6045528A (en) * 1997-06-13 2000-04-04 Intraear, Inc. Inner ear fluid transfer and diagnostic system
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
US6120484A (en) * 1999-02-17 2000-09-19 Silverstein; Herbert Otological implant for delivery of medicament and method of using same

Also Published As

Publication number Publication date
CA2434272A1 (en) 2002-07-25
DE60236639D1 (de) 2010-07-22
CN1487832A (zh) 2004-04-07
JP2004520361A (ja) 2004-07-08
BR0206568A (pt) 2004-01-27
SE0100158D0 (sv) 2001-01-19
JP4960931B2 (ja) 2012-06-27
MXPA03006439A (es) 2003-09-22
CN1307998C (zh) 2007-04-04
JP4202135B2 (ja) 2008-12-24
EP1351693B1 (en) 2010-06-09
HK1061975A1 (en) 2004-10-15
JP2009019043A (ja) 2009-01-29
US20040029970A1 (en) 2004-02-12
US7498360B2 (en) 2009-03-03
EP1351693A1 (en) 2003-10-15
CA2434272C (en) 2011-03-08
AU2002219765B2 (en) 2005-10-27
WO2002056890A1 (en) 2002-07-25
NZ526972A (en) 2005-02-25
ATE470446T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
PL362803A1 (pl) Nowy sposób i kompozycje do miejscowego leczenia choroby Meniere'a, szumu w uszach i/lub utraty słuchu
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
MY127290A (en) New use of flibanserin
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
PT998287E (pt) Utilizacao de levobupivacaina
NZ507203A (en) Use of dexmedetomidine for ICU sedation
GB2368525A (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
DE60128100D1 (de) Analgetisches arzneimittel
NO20013414D0 (no) Ny anvendelse av melagatran
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
AU2002234644A1 (en) Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
UA36428A (uk) Вушна лійка
MD1469F1 (en) Method of treatment of the burn shock
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
MX9503363A (es) N-(2,6-dioxo-3-piperidil) ftalimida (generico talidomida como tratamiento del sindrome de desgaste asociado con la infeccion por vih-1.
UA36030A (uk) Препарат для лікування і профілактики респіраторних хвороб коней " сегп "

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)